New data suggest that Strattera? (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced at a meeting of child and adolescent psychiatrists.
A new study has found that babies that are breastfed for longer than six months have significantly better mental health in childhood. The findings are based on data from the ground-breaking Raine Study at the Telethon Institute for Child Health Research, that has tracked the growth and development of more than 2500 West Australian children over the past 16 years.
Scientists in Hong Kong have identified a protein that can help suppress the growth of prostate cancer cells, the third most common cancer in men worldwide, and the finding might pave the way for the making of a new drug but not so soon.
Pre-school care, combining basic education with health and nutrition programmes, remains the missing link for millions of children in developing countries, and early childhood programmes can make for strong foundations and pay high dividends.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.
All parties with an interest in the upcoming Intergovernmental Working Group on Public Health, Innovation and Intellectual Property are invited to present their views to web-based public hearings organized by the World Health Organization (WHO).
World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.
A research consortium, supported by the National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), today announced the publication of a high-quality draft genome sequence of the western honey bee, finding that its genome is more similar to humans than any insect sequenced thus far.
IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted an electronic New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Junovan(TM) (mifamurtide for injection), requesting approval for its use in the treatment of newly diagnosed resectable high grade osteosarcoma patients following surgical resection in combination with multiple agent chemotherapy.
Bayer HealthCare (BHC) and Topsun Science and Technology Co., Ltd. (Topsun, 600771.SS) together announced that BHC’s Consumer Care Division has signed an agreement in China to acquire the Western over-the-counter (OTC) cough and cold portfolio of Topsun Science and Technology Qidong Gaitianli Pharmaceutical Co., Ltd. for the consideration of RMB 1,072 million (approximately EUR 103 million) plus contingent payments of RMB 192 million (approximately EUR 19 million) subject to fulfilment of certain performance criteria.